WHO – Clinical management and infection prevention and control for monkeypox: Interim rapid response guidance, 10 June 2022

Overview

In the context of the current multi-country monkeypox outbreak, WHO has developed interim rapid response guidance for the clinical management and infection prevention and control of monkeypox for health care and community settings.

It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons. The guidance also addresses considerations for clinical management such as the use of therapeutics, nutritional support, mental health services, and post-infection follow-up.

The document provides guidance for clinicians, health facility managers, health workers and infection prevention and control practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, infectious diseases clinics, genitourinary clinics, dermatology clinics, maternity services, paediatrics, obstetrics and gynaecology and acute care facilities that provide care for patients with suspected or confirmed monkeypox.